Corporate Profile

OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health. We are dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices.

ARESTIN^® (minocycline hydrochloride) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a unique microsphere delivery system that works differently than other LAAs. OraPharma is proud to have introduced this revolutionary approach to treating periodontitis as an adjunct to scaling and root planing and continues to take a leadership role in educating clinicians and consumers on the disease. Read more about ARESTIN^®.

Also included in our portfolio, HEALOS^® Bone Graft Substitute, manufactured by DePuy Spine Inc.- a product intended to fill, augment, or reconstruct periodontal and/or bony defects in the upper or lower jaw.

Continuing our mission to offer innovative products, OraPharma acquired
EZ White™ Pro In-Office Whitening System in late 2012. This fast, mild, and effective professional whitening solution rounds out our portfolio by adding brighter-looking smiles to healthy mouths.

Plans for Growth

OraPharma is pursuing strategies to expand our offerings by:

• Investing in additional research to better meet the needs of the field
• Investing in global expansion of the ARESTIN^® brand
• Seeking to significantly expand our portfolio of products to provide more comprehensive solutions for our customers

In order to accomplish these goals, we will continue to build on our strong institutional knowledge and successes in the dental market, optimized by our clinically trained specialty account teams. These teams of experts are unique in the oral healthcare market and offer an unrivaled level of commitment to our customers.
Learn more about what we offer prospective partners.